Figure 1 | Scientific Reports

Figure 1

From: Oral and topical administration of a geranyl acetophenone attenuates DNCB-induced atopic dermatitis-like skin lesions in BALB/c mice

Figure 1

Chemical structure of tHGA and experimental design. (a) The chemical structure of 2,4,6-trigydroxy-3-geranyl acetophenone (tHGA) contains a phloroglucinol structural-core as the bioactive principle. (b) Experimental design: Mice were sensitised with 1% DNCB on day 1. From day 8, mice were challenged with 0.5% DNCB three times per week up to 4 weeks. In the final 2 weeks, orally treated mice were administered different doses of tHGA, drug control or vehicle 1-h prior to DNCB application for 3 days per week, while topical treated mice were applied with different doses of tHGA, drug control or vehicle 4-h prior to DNCB application daily. Mice were observed for scratching behaviour on day 33 and evaluated for SCORAD on day 34 before being sacrificed for blood and skin sample collection.

Back to article page